Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 4/20 | 0.94 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.59 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | CA12 | O43570 | 3/20 | 0.58 |
| ▸ | CA2 | P00918 | 3/20 | 0.58 |
| ▸ | CA9 | Q16790 | 3/20 | 0.58 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.58 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.58 |
| ▸ | LMNA | P02545 | 1/20 | 0.58 |
| ▸ | CA5A | P35218 | 1/20 | 0.58 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.58 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.58 |
| ▸ | RAPGEF4 | Q8WZA2 | 1/20 | 0.47 |
| ▸ | TSHR | P16473 | 2/20 | 0.46 |
| ▸ | HSD17B1 | P14061 | 2/20 | 0.46 |
| ▸ | HSD17B2 | P37059 | 2/20 | 0.46 |
| ▸ | CA1 | P00915 | 2/20 | 0.46 |
| ▸ | CA7 | P43166 | 2/20 | 0.46 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Metacresol SCHEMBL5263200 | 1.00 | — | — | |
| Metacresol SCHEMBL2314567 | 0.97 | ACHE (1.00) | ACHECYP1A2CYP2C19ALDH1A1CA12 | |
| Metacresol SCHEMBL11437600 | 0.97 | ACHE (1.00) | ACHECYP1A2CYP2C19ALDH1A1CA12 | |
| Metacresol SCHEMBL10736 | 0.97 | — | — | |
| Metacresol SCHEMBL9774388 | 0.97 | ACHE (1.00) | ACHECYP1A2CYP2C19ALDH1A1CA12 | |
| Metacresol SCHEMBL29352064 | 0.97 | — | — | |
| Metacresol SCHEMBL6118712 | 0.94 | — | — | |
| Metacresol SCHEMBL7070862 | 0.94 | — | — | |
| Metacresol SCHEMBL5533063 | 0.94 | — | — | |
| Metacresol SCHEMBL6234380 | 0.94 | ACHE (0.94) | ACHECYP1A2CYP2C19ALDH1A1CA12 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-101151253-A | Substituted N- [ pyrimidin-2-yl-methyl ] carboxamides and their use as herbicides and plant growth regulators | BAYER CROPSCIENCE AG (DE) | 2008-03-26 | — | — | CN | disclosed |
| US-20060223708-A1 | Substituted N-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators | BAYER CROPSCIENCE GMBH (DE) | 2006-10-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060223708-A1 | Substituted N-[pyrimidin-2-ylmethyl]carboxamides and their use as herbicides and plant growth regulators | CNPY2, PRXL2A, CBR3 | ACHE 2122/4885CYP1A2 225/4885CYP2C19 1246/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.